Currently funded projects
Targeting a Common Checkpoint of Brain Disease by novel Autotaxin inhibitors
Institution: Institut für Translationale Neurowissenschaften, Westfälische Wilhelms-Universität Münster
Applicant: Prof. Dr. med. Dr. phil. Robert Nitsch
EKFS funding line: Translational Research
Signal-enhanced MRI to democratize cancer diagnostics and staging
Institution: Research Group for NMR Signal Enhancement, Max Planck Institute for Multidisciplinary Sciences, Göttingen
Applicant: Dr. Stefan Glöggler
EKFS funding line: Translational Research
Combined immunotherapy with peptide vaccination and immune checkpoint inhibition for malignant diseases with DNAJB1-PRKACA gene fusions
Institution: University Hospital Tübingen, Department of Peptide-based Immunotherapy and Clinical Collaboration Unit Translational Immunology
Applicant: Prof. Dr. med. Juliane Walz
EKFS funding line: Translational Research
Phase I trial of the bispecific PSMAxCD3 antibody CC-1 in biochemical recurrence of prostate cancer
Institution: Department of Medicine, Clinical Collaboration Unit Translational Immunology, University Hospital Tübingen
Applicant: Dr. Jonas Heitmann
EKFS funding line: Translational Research
Detection of nicotinamide adenine dinucleotide (NAD) in cells and blood plasma
Institution: Charité – Universitätsmedizin Berlin, Experimentelle Chirurgie, Campus Virchow-Klinikum
Applicant: PD Dr. med. Felix Krenzien
EKFS funding line: Translational Research
LOGIBODY – logic-gated antibodies for cancer immunotherapies
Institution: Prof. Dr. Hendrik Dietz – Lehrstuhl für Biomolekulare Nanotechnologie, Technische Universität München
Applicants: Dr. Klaus F. Wagenbauer, Dr. Benjamin Kick and Dr. Jonas J. Funke
EKFS funding line: Translational Research
Translational development of a novel immunohematology technology for detection, specification and pre-analytical depletion of irregular and medicinal antibodies against red cell, platelet and neutrophil antigens
Institution: DRK-Blutspendedienst Baden-Württemberg-Hessen
Institut Frankfurt am Main und Institut für Transfusionsmedizin und Immunhämatologie
Fachbereich Medizin, Johann-Wolfgang-Goethe Universität Frankfurt
Applicant: Prof. Dr. Halvard Bönig
EKFS funding line: Translational Research
Precision immunotherapy: Mutation-specific TCR-T cell therapy for MyD88L265P mutated lymphoma – GMP-grade vector production and establishment of TCR-T cell manufacturing
Institution: Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité – Universitätsmedizin Berlin Campus Benjamin Franklin
Applicant: PD Dr. med. Antonia Busse
EKFS funding line: Translational Research
Upscaling the antibody-protamine-nanocarrier mediated siRNA therapy: Preparation of a clinical phase I study in patients with acute myeloid leukemia (AML)
Institution: Medizinische Klinik A, Labor für Molekulare Hämatologie und Onkologie, Universitätsklinikum Münster
Applicant: Dr. rer. nat. Sebastian Bäumer
EKFS funding line: Translational Research
Development of an interactive app for structured prehabilitation before major surgery – PROTEGO MAXIMA
Institution: Klinik für Allgemein-, Viszeral-, Transplantations- und Thoraxchirurgie, Universitätsklinikum Frankfurt
Applicant: Prof. Dr. Andreas Schnitzbauer
EKFS funding line: Translational Research